Gene Editing Assignment 3 Paper

Gene human editing technology can be used to help in disease eradication. Recently scientist has come up with new ways of hindering mosquitoes from spreading malaria. The use of technology is improving in gene editing that is associated with the causes of human diseases like cancer. Human editing genes have also caused ethical issues in the recent world. Most human diseases have components of genetic. In this case, the contribution and effects of environment usually have variable influence (Liang, Xu, Zhang, Ding, Huang, Zhang, & Sun, 2015).

The human gene editing can be applied in the science laboratory research, to increases biomedical science of human tissue and cells editing human genes become suitable for use. The technology which is used in human gene editing has implication which alters the human gene permanent. The most used tools for gene editing is known as Doudna; this tool is used to carry out DNA inside living cell. Also, many scientists are unraveling human-like animals to see the gene which is associated with them. They have come up with ways of treating cell disease and cancer. They have done experiences of these gene-editing therapies with people. They also use the CRISPR tool to edit human genes. The most pressing ethical difficulty of using these tools is the gene editing can be transmitted to the future generation.

Some principles govern the human gene editing. Those principles include transparency, well-being promotion, science responsibility, due care, fairness, respect for persons and transnational cooperation. The ethical concern about the human gene editing is equity and justice, safety, and informed consent (Gori, Hsu, Maeder, Shen, Welstead, & Bumcrot, 2015).

Reference

Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., ... & Sun, Y. (2015). CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & cell, 6(5), 363-372.

Gori, J. L., Hsu, P. D., Maeder, M. L., Shen, S., Welstead, G. G., & Bumcrot, D. (2015). Delivery and specificity of CRISPR/Cas9 genome editing technologies for human gene therapy. Human gene therapy, 26(7), 443-451.